TickerFacts.

NewGenIvf Group Ltd (NIVF): Shareholders' Equity

Annual figures by period end, from SEC filings.

$25.99M
As of 2025-12-31
n/m
3-year compound annual growth
2021-12-31: -$914.9K2022-12-31: $100.7K2023-12-31: $3.25M2024-12-31: -$1.48M2025-12-31: $25.99M$25.99M
2021-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$25.99Mn/m2026-03-31, Balance as of period end
2024-12-31-$1.48Mn/m2026-03-31, Balance as of period end
2023-12-31$3.25Mn/m2026-03-31, Balance as of period end
2022-12-31$100.7Kn/m2025-05-15, Balance as of period end
2021-12-31-$914.9Kn/a2024-08-20, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
NewGenIvf Group Ltd (NIVF)2025-12-31$25.99Mn/m
Cryo Cell International Inc (CCEL)2025-11-30-$18.61Mn/m
Mangoceuticals, Inc. (MGRX)2025-12-31$15.20M+9.0%
Pacific Health Care Organization Inc (PFHO)2025-12-31$13.07M+11.9%
Marpai, Inc. (MRAI)2025-12-31-$32.56Mn/m
Charming Medical Ltd (MCTA)2026-03-31$5.18Mn/m
Viemed Healthcare, Inc. (VMD)2025-12-31$141.54M+7.7%
BioRestorative Therapies, Inc. (BRTX)2025-12-31$356.7K-95.8%
Progyny, Inc. (PGNY)2025-12-31$516.04M+22.3%

Compare NIVF, CCEL, MGRX, PFHO side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗